# ROSPA - Record on Satisfaction of Patients With Actonel 35 mg Once a Week

> **NCT00544180** · PHASE4 · TERMINATED · sponsor: **Sanofi** · enrollment: 7 (actual)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** Risedronate

## Key facts

- **NCT ID:** NCT00544180
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-05
- **Primary completion:** 2006-09
- **Final completion:** —
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** The trial was terminated due to lack of compliance with GCP regulations.
- **Last updated:** 2009-09-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00544180

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00544180, "ROSPA - Record on Satisfaction of Patients With Actonel 35 mg Once a Week". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00544180. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*